Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25819777 | 1.00 | ALOX15 (0.49) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL18776608 | 1.00 | ALOX15 (0.49) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL17627753 | 1.00 | ALOX15 (0.49) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL24245828 | 1.00 | ALOX15 (0.49) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL18776603 | 1.00 | ALOX15 (0.49) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL24722699 | 1.00 | ALOX15 (0.49) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL7676876 | 1.00 | ALOX15 (0.49) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL8737953 | 1.00 | ALOX15 (0.49) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL7676869 | 1.00 | ALOX15 (0.49) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL24245641 | 0.87 | ALOX15 (0.44) | ALOX15ALDH1A1LMNATHRBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014065-A1 | PHYTOCHEMICAL INFUSED COSMETIC COMPOSITIONS AND THERAPEUTIC USES THEREOF | Dewey Beauty LLC (US) | 2026-01-15 | — | — | US | claimed |
| EP-4655373-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2025-12-03 | — | — | EP | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| WO-2024156688-A1 | BIODEGRADABLE PERFUME COMPOSITION | GIVAUDAN SA (CH) | 2024-08-02 | — | — | WO | claimed |
| EP-4407019-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2024-07-31 | — | — | EP | claimed |
| US-20220364016-A1 | PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2022-11-17 | — | — | US | claimed |
| EP-4025675-A1 | A PERFUME OIL MIXTURE | Symrise AG (DE) | 2022-07-13 | — | — | EP | claimed |
| CN-114364773-A | Aromatic oil mixture | 西姆莱斯股份公司 | 2022-04-15 | — | — | CN | claimed |
| EP-3365418-A2 | PARTICLES FOR MALODOR REDUCTION | The Procter and Gamble Company (US) | 2018-08-29 | — | — | EP | claimed |
| WO-2017070131-A2 | PARTICLES FOR MALODOR REDUCTION | THE PROCTER & GAMBLE COMPANY (US) | 2017-04-27 | — | — | WO | claimed |
| EP-4192614-B1 | PROCESS FOR THE PREPARATION OF MICROCAPSULES | SYMRISE AG (DE) | 2026-05-06 | — | — | EP | disclosed |
| EP-4025675-B1 | A PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2026-03-18 | — | — | EP | disclosed |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC (US) | 2026-01-29 | — | — | US | disclosed |
| US-20260014065-A1 | PHYTOCHEMICAL INFUSED COSMETIC COMPOSITIONS AND THERAPEUTIC USES THEREOF | Dewey Beauty LLC (US) | 2026-01-15 | — | — | US | disclosed |
| WO-2011163133-A1 | ALIPHATIC POLYCARBONATES | NOVOMER, INC. (US) | 2011-12-29 | — | — | WO | disclosed |
| US-20110098209-A1 | ENCAPSULATES | SMETS JOHAN | 2011-04-28 | — | — | US | disclosed |
| US-20100248390-A1 | COMPOSITIONS AND METHODS FOR IDENTIFYING LIGANDS OF ODORANT RECEPTORS | DUKE UNIVERSITY (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100190673-A1 | ENCAPSULATES | THE PROCTER & GAMBLE COMPANY | 2010-07-29 | — | — | US | disclosed |
| US-20100111888-A1 | Organic Compounds and Compositions Having the Ability to Modulate Fragrance Compositions | GIVAUDAN SA (CH) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR1, CNR2, OPRM1 | ALOX15 11/4885ALDH1A1 1420/4885LMNA 293/4885 |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | ALOX15 121/4885ALDH1A1 4768/4885LMNA 3179/4885 |
| US-20100111888-A1 | Organic Compounds and Compositions Having the Ability to Modulate Fragrance Compositions | CYP2A13, CYP1A1, CYP1B1 | ALOX15 35/4885ALDH1A1 139/4885LMNA 3819/4885 |
| US-20260014065-A1 | PHYTOCHEMICAL INFUSED COSMETIC COMPOSITIONS AND THERAPEUTIC USES THEREOF | DHCR24, CNR2, DSG1 | ALOX15 204/4885ALDH1A1 1504/4885LMNA 790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.